A phase I trial of aprinocarsen (ISIS 3521/LY900003), an...

Investigational New Drugs 2005 / 10 Vol. 23; Iss. 5

A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-α administered as a 24-hour weekly infusion schedule in patients with advanced cancer

Ranjana Advani, Bert L. Lum, George A. Fisher, Joanne Halsey, Richard S. Geary, Jon T. Holmlund, T. Jesse Kwoh, F. Andrew Dorr, Branimir I. Sikic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
english
Pages:
11
DOI:
10.1007/s10637-005-2906-0
Date:
October, 2005
File:
PDF, 123 KB
english, 2005
Conversion to is in progress
Conversion to is failed